[GBSN] Great Basin Scientific, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.01 Change: -0 (-19.35%)
Ext. hours: Change: 0 (0%)

chart GBSN

Refresh chart

Strongest Trends Summary For GBSN

GBSN is in the long-term down -100% below S&P in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Great Basin Scientific, Inc., a molecular diagnostics company, develops and manufactures test kits and analyzers for a patented molecular diagnostic system used in single pathogen tests. The company provides a medical diagnostic test for the detection of Clostridium difficile, a gram-positive bacteria that causes diarrhea and other intestinal disorders. Its products under development comprise a diagnostic test for Group B streptococcus, a bacterium that colonizes in the warm moist areas of various humans, as well as a test for blood infections caused by Staphylococcus bacteria, a pre-surgical nasal screen for Staphylococcus aureus, and a food borne pathogen test. The company sells its diagnostic tests through a direct sales force in the United States, as well as through distributors in the European Union and New Zealand. The company was formerly known as Diagnostic Micro Arrays, Inc. and changed its name to Great Basin Scientific, Inc. in April 2006. Great Basin Scientific, Inc. is headquartered in Salt Lake

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1076.92% Sales Growth - Q/Q3.15% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-353.59% ROE119.12% ROI
Current Ratio4.25 Quick Ratio4.16 Long Term Debt/Equity5.99 Debt Ratio-0.07
Gross Margin-184.76% Operating Margin-1277.22% Net Profit Margin-6966.72% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities22.32 M Cash From Investing Activities-160 K Cash From Operating Activities-3.59 M Gross Profit-510 K
Net Profit-71.17 M Operating Profit-3.88 M Total Assets26.64 M Total Current Assets21.94 M
Total Current Liabilities5.16 M Total Debt3.71 M Total Liabilities105.71 M Total Revenue460 K
Technical Data
High 52 week14 Low 52 week0.05 Last close0.11 Last change-5.01%
RSI31.54 Average true range0.01 Beta0.58 Volume19.32 M
Simple moving average 20 days-8.82% Simple moving average 50 days-11.78% Simple moving average 200 days-39.72%
Performance Data
Performance Week-8.33% Performance Month-12.97% Performance Quart-8.86% Performance Half69.23%
Performance Year-97.25% Performance Year-to-date-10.93% Volatility daily3.8% Volatility weekly8.5%
Volatility monthly17.43% Volatility yearly60.37% Relative Volume466.83% Average Volume118.71 K
New High New Low-0%

News

2017-07-18 09:00:00 | SeeThruEquity Issues Update on Great Basin Scientific GBSN on FDA Clearance

2017-07-13 07:00:00 | Great Basin Scientific Receives FDA 510k Clearance for Stool Bacterial Pathogens Panel

2017-07-05 09:00:00 | SeeThruEquity Issues Update on Great Basin Scientific GBSN

2017-06-26 07:00:00 | Great Basin Scientific Provides Business Update

2017-06-22 07:00:00 | Great Basin Scientific Closes $2.7 Million Offering of Units

2017-06-20 09:28:56 | Great Basin Scientific Prices $2.7 Million Registered Offering of Units

2017-06-02 09:58:07 | Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

2017-06-01 07:00:00 | Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin’s Stool Bacterial Pathogens Panel

2017-05-24 07:00:00 | Great Basin Scientific Issued Second U.S. Patent for PCR Amplification Suppressor

2017-05-22 07:00:00 | Great Basin Scientific Reports First Quarter 2017 Results

2017-05-16 07:00:00 | Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test

2017-05-15 07:00:00 | Great Basin Scientific Obtains Release of $1.36 Million of Restricted Cash from Series B Convertible Notes

2017-05-08 15:21:46 | Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: Q4, 2016 By the Numbers : May 8, 2017

2017-05-08 13:12:10 | Great Basin Scientific, Inc. :GBSN-US: Earnings Analysis: 2016 By the Numbers : May 8, 2017

2017-05-05 07:00:00 | Great Basin Scientific Stock Symbol Reverts to GBSN

2017-04-12 07:00:00 | Great Basin Scientific Receives CE Marking for Stool Bacterial Pathogens Panel

2017-04-10 09:08:38 | Great Basin Scientific Announces Restructuring of Convertible Securities

2017-04-07 16:01:00 | Great Basin Scientific Announces Date of Effectiveness of Reverse Stock Split

2017-04-07 08:30:00 | Great Basin What's Next in the Pipeline Following FDA Clearance for Bordetella Direct Test

2017-04-06 07:30:00 | Study Published in PLOS ONE Demonstrates Effectiveness of Great Basin Scientific’s Patented Amplification Suppressor Technology

2017-04-03 16:00:00 | Great Basin Scientific Receives FDA 510k Clearance for Bordetella Direct Test

2017-03-22 07:03:23 | Great Basin Scientific Reports Fourth Quarter and Full Year 2016 Results

2017-03-22 07:01:46 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements

2017-03-10 07:17:42 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD D

2017-03-09 20:55:14 | Great Basin Scientific Receives Stockholder Approval for Reverse Stock Split and Authorized Share Increase During Special Meeting

2017-03-03 16:54:10 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ

2017-03-02 07:30:00 | Great Basin Scientific’s Suzette Chance Named a 2017 Woman Worth Watching in STEM by Profiles in Diversity Journal

2017-03-02 06:39:17 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to

2017-02-24 17:17:15 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rig

2017-02-17 06:06:31 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Material Modification

2017-02-16 17:15:38 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to

2017-02-15 07:30:00 | Great Basin Scientific’s Staph ID/R Blood Culture Panel Clinical Evaluation and Rapid Identification Analysis Published in Journal of Clinical Microbiology

2017-02-14 08:45:00 | Great Basin Scientific Announces Filing of Registration Statement on Form S-1

2017-02-14 08:39:58 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and

2017-02-10 09:17:06 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Regulation FD Dis

2017-02-10 09:00:00 | Great Basin Scientific Announces Corporate Restructuring and Reduction in Principal of 2016 Convertible Note

2017-02-03 17:12:07 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rig

2017-02-03 07:00:00 | Great Basin Scientific’s Shiga Toxin Direct Test Clinical Evaluation and Cost Analysis Published in Journal of Clinical Microbiology

2017-02-02 08:18:21 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Other Events

2017-02-01 07:00:00 | Great Basin Scientific Completes Clinical Trial, Submits FDA 510k Application for Bordetella Direct Test

2017-01-31 08:59:01 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to

2017-01-26 07:30:00 | Great Basin Scientific Stock Symbol Reverts to GBSN

2017-01-26 06:06:37 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rig

2017-01-24 09:26:04 | Great Basin Scientific Announces Preliminary Fourth Quarter 2016 Revenue

2017-01-20 08:30:00 | Great Basin Announces Request to Withdraw S-1 Registration Statement and Amendment to $75 Million 2016 Convertible Note

2016-12-28 11:17:09 | Great Basin Scientific Stock Symbol Temporarily Changed to GBSND

2016-12-28 07:30:00 | Great Basin Announces Effectiveness of Reverse Stock Split of Common Stock and Authorized Share Increase

2016-12-23 06:03:49 | GREAT BASIN SCIENTIFIC, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to A

2016-12-22 18:45:09 | Great Basin Scientific Shareholders Approve Reverse Stock Split and Authorized Share Increase During Special Meeting

2016-12-19 07:30:00 | Great Basin Scientific Submits 510k Application to the FDA for Stool Bacterial Pathogens Panel